Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - cilazapril monohydrate 5.22mg equivalent to 5.0 mg cilazapril, anhydrous;  ; hydrochlorothiazide 12.5mg;  ;  ;   - tablet - active: cilazapril monohydrate 5.22mg equivalent to 5.0 mg cilazapril, anhydrous   hydrochlorothiazide 12.5mg       excipient: hypromellose   iron oxide red lactose monohydrate maize starch purified talc   sodium stearyl fumarate titanium dioxide - the treatment of patients with hypertension who are not adequately controlled on monotherapy

Israel - Englisch - Ministry of Health

unipharm ltd, israel - cilazapril; hydrochlorothiazide - tablets - cilazapril 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - cilazapril monohydrate 0.522mg equivalent to 0.5 mg cilazapril, anhydrous;   - tablet - 0.5 mg - active: cilazapril monohydrate 0.522mg equivalent to 0.5 mg cilazapril, anhydrous   excipient: hypromellose   lactose monohydrate maize starch opadry white 03a28439 purified talc   sodium stearyl fumarate titanium dioxide

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

viatris limited - cilazapril monohydrate 5.22mg equivalent to cilazapril 5 mg - film coated tablet - 5 mg - active: cilazapril monohydrate 5.22mg equivalent to cilazapril 5 mg excipient: colloidal silicon dioxide lactose opadry brown 40l16820 pregelatinised maize starch sodium bicarbonate sodium stearyl fumarate - zapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. zapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

Belgien - Englisch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cheplapharm arzneimittel gmbh - cilazapril monohydrate 5,22 mg - eq. cilazapril 5 mg; hydrochlorothiazide 12,5 mg - film-coated tablet - 5 mg - 12,5 mg - cilazapril monohydrate 5.22 mg; hydrochlorothiazide 12.5 mg - cilazapril and diuretics

Belgien - Englisch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cheplapharm arzneimittel gmbh - cilazapril monohydrate 0,522 mg - eq. cilazapril 0,5 mg - film-coated tablet - 0,5 mg - cilazapril monohydrate 0.522 mg - cilazapril

Belgien - Englisch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cheplapharm arzneimittel gmbh - cilazapril monohydrate 5,22 mg - eq. cilazapril 5 mg - film-coated tablet - 5 mg - cilazapril monohydrate 5.22 mg - cilazapril

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

viatris limited - cilazapril monohydrate 2.61mg equivalent to cilazapril 2.5 mg - film coated tablet - 2.5 mg - active: cilazapril monohydrate 2.61mg equivalent to cilazapril 2.5 mg excipient: colloidal silicon dioxide lactose opadry pink 40l14839 pregelatinised maize starch sodium bicarbonate sodium stearyl fumarate - zapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. zapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

Israel - Englisch - Ministry of Health

unipharm ltd, israel - cilazapril - tablets - cilazapril 2.5 mg - cilazapril - cilazapril - a blood pressure lowering agent. chronic heart failure.

Israel - Englisch - Ministry of Health

unipharm ltd, israel - cilazapril - tablets - cilazapril 5 mg - cilazapril - cilazapril - a blood pressure lowering agent. chronic heart failure.